Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Augustin

Showing results (151-160 of 491) with videos related to

Pageof 50
Sort By:
Archives of Dermatological Research|June 24, 2018
How to weight patient-relevant treatment goals for assessing treatment benefit in psoriasis: preference elicitation methods vs. rating scalesMandy Gutknecht, Marthe-Lisa Schaarschmidt, Marion Danner, et al.
The Journal of Dermatological Treatment|January 25, 2011
Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasisSilas Martin, Steven R Feldman, Matthias Augustin, et al.
Arzneimittel-Forschung|February 25, 2005
Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and SwitzerlandMatthias Augustin, Paul R Bock, Jürgen Hanisch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 19, 2017
Krankheitsverlauf, medizinische Versorgung und Lebensqualität von Patienten mit kongenitalen melanozytären Nävi - Auswertung des deutschsprachigen KMN-RegistersMaria Elisabeth Wramp, Anna Langenbruch, Matthias Augustin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 22, 2023
Development of Measurement Tools to Assess Cumulative Life Course Impairment in Patients with Chronic Skin DiseasesCatharina C Braren-von Stülpnagel, Matthias Augustin, Lukas Westphal, et al.
Skin Health and Disease|February 8, 2023
Methods used for indirect comparisons of systemic treatments for psoriasis. A systematic reviewAlexander Nast, Corinna Dressler, Christopher Schuster, et al.
Healthcare (Basel, Switzerland)|September 23, 2022
Medicinal Treatment of Elderly Psoriasis Patients before and after Entering a Nursing HomeJana Petersen, Claudia Garbe, Sandra Wolf, et al.
European Journal of Dermatology : EJD|June 16, 2004
Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold systemMatthias Augustin, Sabine Lange, Kerstin Wenninger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 29, 2024
Treatment adjustment in biologic therapies for moderate-to-severe plaque psoriasis: a German retrospective chart review (TABU)Natalia Kirsten, Simone Rubant, Susana Gomis-Kleindienst, et al.
Research in Health Services & Regions|August 23, 2024
Psoriasis care in Germany: do patients who receive better care travel longer?Nicole Mohr, Anna Langenbruch, Jobst Augustin, et al.
Pageof 50

Showing results (151-160 of 491) with videos related to

Sort By:
Pageof 50
Archives of Dermatological Research|June 24, 2018
How to weight patient-relevant treatment goals for assessing treatment benefit in psoriasis: preference elicitation methods vs. rating scalesMandy Gutknecht, Marthe-Lisa Schaarschmidt, Marion Danner, et al.
The Journal of Dermatological Treatment|January 25, 2011
Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasisSilas Martin, Steven R Feldman, Matthias Augustin, et al.
Arzneimittel-Forschung|February 25, 2005
Safety and efficacy of the long-term adjuvant treatment of primary intermediate- to high-risk malignant melanoma (UICC/AJCC stage II and III) with a standardized fermented European mistletoe (Viscum album L.) extract. Results from a multicenter, comparative, epidemiological cohort study in Germany and SwitzerlandMatthias Augustin, Paul R Bock, Jürgen Hanisch, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|February 19, 2017
Krankheitsverlauf, medizinische Versorgung und Lebensqualität von Patienten mit kongenitalen melanozytären Nävi - Auswertung des deutschsprachigen KMN-RegistersMaria Elisabeth Wramp, Anna Langenbruch, Matthias Augustin, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 22, 2023
Development of Measurement Tools to Assess Cumulative Life Course Impairment in Patients with Chronic Skin DiseasesCatharina C Braren-von Stülpnagel, Matthias Augustin, Lukas Westphal, et al.
Skin Health and Disease|February 8, 2023
Methods used for indirect comparisons of systemic treatments for psoriasis. A systematic reviewAlexander Nast, Corinna Dressler, Christopher Schuster, et al.
Healthcare (Basel, Switzerland)|September 23, 2022
Medicinal Treatment of Elderly Psoriasis Patients before and after Entering a Nursing HomeJana Petersen, Claudia Garbe, Sandra Wolf, et al.
European Journal of Dermatology : EJD|June 16, 2004
Validation of a comprehensive Freiburg Life Quality Assessment (FLQA) core questionnaire and development of a threshold systemMatthias Augustin, Sabine Lange, Kerstin Wenninger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 29, 2024
Treatment adjustment in biologic therapies for moderate-to-severe plaque psoriasis: a German retrospective chart review (TABU)Natalia Kirsten, Simone Rubant, Susana Gomis-Kleindienst, et al.
Research in Health Services & Regions|August 23, 2024
Psoriasis care in Germany: do patients who receive better care travel longer?Nicole Mohr, Anna Langenbruch, Jobst Augustin, et al.
Pageof 50